Company intelligence / Profile preview

Medeval

Manchester, United Kingdom

Ownership: Private
Development stage: Other

Overview

Medeval was a leading UK-based clinical research organization (CRO) specializing in Phase I and early Phase II clinical pharmacology studies. Founded in 1983 as a spin-out from the University of Manchester, the company established a strong reputation for its expertise in pharmacokinetics and clinical trial design. Medeval operated a dedicated clinical unit and provided comprehensive services including protocol design, data management, and regulatory consultancy to global pharmaceutical and biotechnology companies. In 2003, the company was acquired by ICON plc, a global provider of outsourced development services, to enhance its early-phase clinical trial capabilities in Europe.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Medeval.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medeval.

Explore the full profile